The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines formulated to target the XFG variant, offering renewed protection against recent strains of the virus.
Among the newly approved options is Pfizer-BioNTech's COMIRNATY vaccine. This updated formula is authorized for individuals aged 5 and older who have underlying medical conditions, as well as all adults aged 65 and older.
Source Attribution: Article content originally reported by Currents Source. Read original story coverage on Currents Source →
